Non-invasive diagnosis of liver diseases by breath analysis using an optimized ionmolecule reaction-mass spectrometry approach: A pilot study

Biomarkers

Volumn 15, Issue 4, 2010, Pages 297-306

  Millonig, Gunda ^a,b   Praun, Siegfried ^c   Netzer, Michael ^d   Baumgartner, Christian ^d   Dornauer, Albert ^c   Mueller, Sebastian ^b   Villinger, Johannes ^c   Vogel, Wolfgang ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c V and F Medical Development GmbH   (Austria)

^d UNIVERSITY FOR HEALTH SCIENCES   (Austria)

Author keywords

Diagnostics; Exhalation; Fatty liver; Foetor hepaticus; Mass spectrometry

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; UREA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BREATH ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC ACCURACY; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; ION MOLECULE REACTION MASS SPECTROMETRY; IONIZATION; IRON METABOLISM; LIVER CIRRHOSIS; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; NON INVASIVE PROCEDURE; NONALCOHOLIC FATTY LIVER; PILOT STUDY; PROCESS OPTIMIZATION; PROTEIN BLOOD LEVEL; QUALITY CONTROL; REPRODUCIBILITY; UREA BLOOD LEVEL;

ACETALDEHYDE; ADULT; AGED; BIOLOGICAL MARKERS; BREATH TESTS; BUTADIENES; ETHANOL; FATTY LIVER; FATTY LIVER, ALCOHOLIC; FEMALE; HEMITERPENES; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MASS SPECTROMETRY; MIDDLE AGED; PENTANES; PILOT PROJECTS;

EID: 77952538454     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/13547501003624512     Document Type: Article

References (38)

1. Adachi Y, Moore LE, Bradford BU, Gao W, Turman RG. (1995). Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108:218-24.
2. Baraona E, Julkunen R, Tannenbaum L, Lieber CS. (1986). Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 90:103-10.
3. Baumgartner C, Baumgartner D. (2006). Biomarker discovery, disease classification, and similarity query processing on highthroughput MS/MS data of inborn errors of metabolism. J Biomol Screen 11:90-9.
4. Bennett L, Ciaffoni L, Denzer W, Hancock G, Lunn AD, Peverall R, Praun S, Ritchie GAD. (2009). A chemometric study on human breath mass spectra for biomarker identification in cystic fibrosis. J Breath Res 3:7-9.
5. Bohadana A, Michaely JP, Teculescu D, Wild P. (2008). Reproducibility of exhaled nitric oxide in smokers and non-smokers: relevance for longitudinal studies. BMC Pulm Med 8:4.
6. Buszewski B, Ulanowska A, Ligor T, Denderz N, Amann A. (2009). Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. Biomed Chromatogr 23:551-6.
7. Cope K, Risby T, Diehl AM. (2000). Increased gastrointestinal ethanol production in obese mice: implications for fatty liver disease pathogenesis. Gastroenterology 119:1340-7.
8. 2-controlled alveolar gas monitoring. J Breath Res 2:10-12.
9. Futrell, J. H. (1986). Gaseous Ion Chemistry and Mass Spectrometry. Hoboken, NJ, USA: John Wiley & Sons. p. 141.
10. Hornuss C, Praun S, Villinger J, Dornauer A, Moehnle P, Dolch M, Weninger E, Chouker A, Feil C, Briegel J, Tiel M, Schelling G. (2007). Real-time monitoring of propofol in expired air in humans undergoing total intravenous anesthesia. Anesthesiology 106:665-74.
11. Jones A W (1985). Excretion of low-molecular weight volatile substances in human breath: focus on endogenous ethanol. J Anal Toxicol 9:246-50.
12. Jones AW, Ostrovsky YuM, Wallin A, Midtvedt T. (1984). Lack of differences in blood and tissue concentrations of endogenous ethanol in conventional and germfree rats. Alcohol 1:393-6.
13. Jordan A, Hansel A, Holzinger R, Lindinger W. (1995). Acetonitrile and benzene in the breath of smokers and non-smokers investigated by proton transfer reaction mass spectrometry (PTR-MS). Int J Mass Spectr Ion Process 148:1-3.
14. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. (1994). Increased nitric oxide in exhaled air of asthmatic patients. Lancet 343:133-5.
15. Kononenko I. (1994). Estimating Attributes: Analysis and Extensions of Relief. Berlin, Heidelberg, Germany: Springer. p. 171-82.
16. Mazzanti R, Moscarella S, Bensi G, Altavilla A, Gentilini P. (1989). Hepatic lipid peroxidation and aldehyde dehydrogenase activity in alcoholic and non alcoholic liver disease. Alcohol Alcohol 24:121-8.
17. Mazzone PJ. (2008). Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Torac Oncol 3:774-80.
18. Nair S, Cope K, Risby TH, Diehl AM. (2001). Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of nonalcoholic steatohepatitis. Am J Gastroenterol 96:1200-4.
19. Nanji AA, Khettry U, Sadrzadeh SM. (1994). Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc Soc Exp Biol Med 205:243-7.
20. Netzer M, Millonig G, Osl M, Pfeifer B, Praun S, Villinger J, Vogel W, Baumgartner C. (2009). A new ensemble-based algorithm for identifying breath gas marker candidates in liver disease using ion molecule reaction mass spectrometry. Bioinformatics 25:941-7.
21. Oneta CM, Lieber CS, Li J, Ruttimann S, Schmid B, Lattmann J, Rosman AS, Seitz HK. (2002). Dynamics of cytochrome P4502E1 activity in man: induction by ethanol and disappearance during withdrawal phase. J Hepatol 36:47-52.
22. Periago JF, Morente A, Villanueva M, Luna A. (1994). Correlation between concentrations of n-hexane and toluene in exhaled and environmental air in an occupationally exposed population. J Appl Toxicol 14:63-7.
23. Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo RN. (1999). Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl 729:75-88. (Pubitemid 29264111)
24. Quinlan RJ. (1993). Programs for machine learning. In: Quinlan RJ. Morgan Kaufmann Series in Machine Learning. San Francisco, CA, USA: Morgan Kaufmann Publishers. C4.5.
25. Risby TH, Sehnert SS. (1999). Clinical application of breath biomarkers of oxidative stress status. Free Radic Biol Med 27:1182-92.
26. Sehnert SS, Jiang L, Burdick JF, Risby TH. (2002). Breath biomarkers for detection of human liver diseases: preliminary study. Biomarkers 7:174-87.
27. Seitz HK, Stickel F. (2007). Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer 7:599-612.
28. Solga SF, Alkhuraishe A, Cope K, Tabesh A, Clark JM, Torbenson M, Schwartz S, Magnuson T, Diehl AM, Risby TH. (2006). Breath biomarkers and non-alcoholic fatty liver disease: preliminary observations. Biomarkers 11:174-83.
29. Spinucci G, Guidetti M, Lanzoni E, Pironi L. (2006). Endogenous ethanol production in a patient with chronic intestinal pseudoobstruction and small intestinal bacterial overgrowth. Eur J Gastroenterol Hepatol 18:799-802.
30. Stone BG, Besse TJ, Duane WC, Evans CD, DeMaster EG. (1993). Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men. Lipids 28:705-8.
31. Takahashi T, Lasker JM, Rosman AS, Lieber CS. (1993). Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology 17:236-45.
32. Takalo R, Piirila P, Sovijarvi AR. (2008). Repeatability of successive measurements with a portable nitric oxide analyser in patients with suggested or diagnosed asthma. Scand J Clin Lab Invest 68:830-2.
33. Tangerman A, Meuwese-Arends MT, van Tongeren JH. (1983). A new sensitive assay for measuring volatile sulphur compounds in human breath by Tenax trapping and gas chromatography and its application in liver cirrhosis. Clin Chim Acta 130:103-10.
34. Tegtmeyer U, Weiss HP, Schlögl R. (1993). Gas analysis by IMR-MS: a comparison to conventional mass spectrometry. Fresenius J Anal Chem 347:263-8.
35. Van den Velde S, Nevens F, Van Hee P, van Steenberghe D, Quirynen M. (2008). GC-MS analysis of breath odor compounds in liver patients. J Chromatogr B Analyt Technol Biomed Life Sci 875:344-8.
36. Wallace L, Pellizzari E, Hartwell TD, Perritt R, Ziegenfus R. (1987). Exposures to benzene and other volatile compounds from active and passive smoking. Arch Environ Health 42:272-9.
37. Wang Y, Millonig G, Nair J, Patsenker E, Stickel F, Mueller S, Bartsch H, Seitz HK. (2009). Ethanol-induced cytochrome P4502E1 causes carcinogenic etheno-DNA lesions in alcoholic liver disease. Hepatology 50:453-61.
38. Weltman MD, Farrell GC, Hall P, Ingelman-Sundberg M, Liddle C. (1998). Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27:128-33.